The 2023 LOI process for all types of Curebound grants is now open as of May 1. To be eligible to receive funding for a 2023 Discovery Grant, Targeted Grant or Cure Prize, applicants must submit a LOI between May 1 and May 30 using the official form available for download below. All forms are due to firstname.lastname@example.org by midnight PST on May 30 to be considered for 2023 funding.
Any questions regarding the form or process may also be sent to email@example.com.
2023 grant process timeline:
All project teams that apply for Curebound grant funding must have at least one lead investigator on staff at one of six research partner institutions.
*Includes UC San Diego Health and affiliated institutions i.e., Moores Cancer Center, San Diego State University, and J. Craig Venter Institute.
Proposals must align with at least one or more of the following Curebound Research Pillars to be funded:
Will be considered for funding in the following three ways:
Discovery Grants: Curebound will fund seed grants for high-risk high-reward innovative, collaborative research. Discovery Grants are intended to fund early-stage ideas and recent breakthroughs from the investigators’ ongoing research accelerating them towards the clinic. Discovery Grants will prioritize research that advances therapeutic development and/or has a high likelihood of leveraging extramural funding. Inter-institutional collaboration is required, if you need help finding a collaborator with the right expertise send us an email at firstname.lastname@example.org
Targeted Grants: Curebound will fund innovative, translational, oncology-based projects that show promise of advancing to pre-clinical or clinical stages. Priority will be given to applications that have a high likelihood of significantly advancing detection, prevention, therapeutic development, access to patient care and/or clinical trials. Targeted Grants will fund continuity of ideas from the investigators’ past research, including research that builds upon previously funded Discovery Grants or Pedal Pilot grants. Interdisciplinary collaboration is required and inter-institutional collaboration, while not required, is preferred.
Cure Prize: Curebound’s Scientific Board will award its prestigious annual Cure Prize to fund innovative ground-breaking ideas that change the course of cancer research and care. Cure Prizes will be awarded to teams who present collaborative and/or inter-disciplinary solutions that show near-term promise of clinical breakthrough and represent “game changers” in the prevention, diagnosis, access or treatment of cancer patients.